The turning point in the fight against the Coronavirus it could come from Johnson & Johnson. A booster dose of the J&J vaccine “generated a increased antibodies 9 times compared to 28 days after the first dose. “The same company points out in a note. The data comes from two phase 2 studies conducted in the United States and Europe on 2,000 participants in anticipation of the potential need for a booster Data were presented in pre-publication on medRxiv. In July, the company had released provisional data, published on New England Journal of Medicine, who demonstrated a stable immune response for eight months after immunization.
“We know that a single dose of our vaccine generates strong and robust immune responses that are durable and persistent for eight months,” he said. Mathai Mammen, Head of Research and Development of Janssen – With these new data we are seeing that a booster dose of the vaccine to study participants, who were previously immunized with our vaccine, further increases antibody responses. “J&J is in dialogue with the FDA, CDC and EMA on the need to offer a booster dose of the Janssen vaccine. “We look forward to discussing the potential strategy for our single-dose vaccine with public health officials, considering a booster eight months after the first dose.”
– .
